Canopy Growth (CGC) Inventory (2017 - 2026)
Canopy Growth (CGC) posted Inventory of $80.6 million for Q1 2026, up 6.47% sequentially from $75.7 million in Q4 2025, and up 19.99% YoY from $67.2 million in Q1 2025.
Canopy Growth (CGC) Inventory (2017 - 2026) Analysis & Trends
Canopy Growth has reported Inventory for 10 years, with the latest figure at $80.6 million in Q1 2026.
- Quarterly Inventory rose 19.99% year-over-year to $80.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.6 million (up 19.99% YoY) and the FY2026 annual result came in at $80.6 million, up 19.99% from the prior year.
- Inventory climbed to $80.6 million in Q1 2026 per CGC's latest filing, from $75.7 million in the prior quarter.
- Over five years, Inventory peaked at $162.4 million in Q3 2022 and troughed at $57.4 million in Q1 2024.
- A 5-year average of $91.5 million and a median of $67.7 million in 2025 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2026: Inventory tumbled 61.87% in 2023, then rose 19.99% in 2026.
- Over 5 years, Inventory stood at $157.7 million in 2022, then plunged by 59.51% to $63.8 million in 2023, then advanced by 1.76% to $65.0 million in 2024, then increased by 16.51% to $75.7 million in 2025, then grew by 6.47% to $80.6 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $80.6 million, $75.7 million, and $74.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 816.00 Mn |
| 10 | Canopy Growth | 430.71 Mn | 183.70 Mn | 16.08 Mn | 77.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.68 Mn |
| Mar 31, 2026 | 80.59 Mn |
| Dec 31, 2025 | 75.69 Mn |
| Sep 30, 2025 | 74.39 Mn |
| Jun 30, 2025 | 67.71 Mn |
| Mar 31, 2025 | 67.16 Mn |
| Dec 31, 2024 | 64.97 Mn |
| Sep 30, 2024 | 66.04 Mn |
| Jun 30, 2024 | 61.79 Mn |
| Mar 31, 2024 | 57.36 Mn |
| Dec 31, 2023 | 63.84 Mn |
| Sep 30, 2023 | 65.25 Mn |
| Jun 30, 2023 | 105.76 Mn |
| Mar 31, 2023 | 61.56 Mn |
| Dec 31, 2022 | 157.69 Mn |
| Sep 30, 2022 | 162.36 Mn |
| Jun 30, 2022 | 161.21 Mn |
| Mar 31, 2022 | 161.48 Mn |
| Dec 31, 2021 | 290.16 Mn |
| Sep 30, 2021 | 280.67 Mn |